Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

This publication has 71 references indexed in Scilit:

• A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy
  Breast Cancer Research and Treatment, 2007
• Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia
  Journal of Medical Economics, 2007
• The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population
  Archives of Gerontology and Geriatrics, 2006
• Changes in quality of life during palliative chemotherapy for solid cancer
  Supportive Care in Cancer, 2005
• Quality of life in patients with osteoporosis
  Osteoporosis International, 2004
• Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer
  European Journal of Cancer, 2004
• Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain
  Journal of Clinical Oncology, 2003
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI: Journal of the National Cancer Institute, 1993
• EuroQol - a new facility for the measurement of health-related quality of life
  Health Policy, 1990
• Measuring the quality of life of cancer patients
  Journal of Chronic Diseases, 1981